November 28, 2024 - 06:05

Researchers at the University of Twente, Netherlands, have made an advancement in bioprinting technology that could transform how we create vascularized tissues. Their innovative bioink enables precise 3D printing of blood vessels, paving the way for significant improvements in regenerative medicine and tissue engineering. This breakthrough could lead to enhanced methods for developing artificial organs and improving transplant success rates. The technology utilizes DNA-based materials to create a more accurate and functional representation of vascular structures, which are crucial for supplying nutrients and oxygen to tissues. As this research progresses, it holds the potential to greatly impact healthcare and the future of medical treatments.
July 1, 2026 - 12:50
BD (BDX) Receives Vizient Innovative Technology Contract for CentroVena One Insertion SystemBecton, Dickinson and Company, known as BD and traded under the ticker BDX, has secured a notable designation for its CentroVena One Insertion System. On June 23, the company announced that Vizient...
June 30, 2026 - 22:45
Why gender diversity matters in technologyIn an industry that often celebrates disruption and innovation, technology still struggles with a glaring lack of diversity. But the conversation around gender representation in tech is shifting...
June 30, 2026 - 01:40
Eye-tracking technology helps researchers see IV pump safety through student nurses' eyesResearchers at the University of Massachusetts Amherst are putting eye-tracking headsets on student nurses to get a fresh look at the safety of intravenous smart pumps. Instead of relying on...
June 29, 2026 - 04:07
Why Everyone's Talking About Poet Technologies Stock Right NowInvestors are turning their focus to Poet Technologies, a company that has quietly moved into the spotlight as the artificial intelligence boom shifts from software to hardware. While much of the...